Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp. shareholder Angelo M. Ninivaggi has filed a Form 144 notice to sell 4,303 shares of common stock through Morgan Stanley Smith Barney on NASDAQ around February 5, 2026, with an indicated aggregate market value of $873,767.18. The shares to be sold were acquired from the issuer as 2,683 restricted stock shares on January 31, 2025 and 1,620 performance shares on November 13, 2024, both noted as not requiring separate cash payment. The filing also reports prior sales over the past three months, including 1,347 shares sold on November 26, 2025 for gross proceeds of $195,222.06 and 2,500 shares sold on November 10, 2025 for $363,192.50.
Plexus Corp. Chairman of the Board Dean A. Foate reported insider equity transactions involving common stock and restricted stock units. On February 2, 2026, a trust for which he serves as trustee sold 5,000 Plexus common shares at an average price of $204.8935, leaving 15,000 shares held indirectly by the trust.
On February 3, 2026, 1,370 restricted stock units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock at an exercise price of $0, increasing his directly held common stock to 109,429 shares and reducing his restricted stock unit balance to zero.
Plexus Corp. shareholder David and Constance Foate Joint Revocable Trust has filed a notice of proposed sale of 10,000 shares of common stock of Plexus through broker Robert W. Baird & Co. on the NASDAQ exchange, with an approximate sale date of February 4, 2026.
The filing shows an aggregate market value of 2037800 for these shares and notes that 27,092,389 common shares were outstanding. The shares to be sold were acquired through vesting of restricted and performance stock units in 2019, 2024, and 2025. Over the prior three months, the trust sold 5,000 common shares for gross proceeds of 1024467.
Patrick Jermain filed a notice of proposed sale of 3,587 shares of common stock of the issuer under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on or about 02/04/2026 on the NASDAQ, with an aggregate market value of $732,070.83.
The 3,587 shares were acquired on 01/31/2025 as restricted stock from the issuer, with the payment noted as not applicable. Shares outstanding were 26,774,415 at the time referenced, which is a baseline figure, not the amount being sold. Over the past three months, Jermain sold 2,000 shares on 11/11/2025 for $287,070.00 and 4,841 shares on 02/03/2026 for $987,612.41.
Plexus Corp. Regional President - EMEA Frank Zycinski reported routine equity compensation activity. On January 30, 2026, 1,353 Restricted Stock Units granted under the Plexus Corp. 2016 Omnibus Incentive Plan vested and settled into 1,353 shares of common stock.
On the same date, 677 shares of Plexus common stock, $.01 par value, were disposed of at a price of $199.33 per share. After these transactions, Zycinski directly beneficially owned 1,399 shares of Plexus common stock.
Plexus Corp. regional president Victor Tan reported the vesting of previously granted restricted stock units and the related acquisition of common shares. On January 30, 2026, 3,380 restricted stock units under the Plexus Corp. 2016 Omnibus Incentive Plan vested and settled into 3,380 shares of common stock. After this transaction, Tan directly held 14,435 shares of Plexus Corp. common stock, reflecting his updated ownership position following the equity award vesting.
Plexus Corp. Regional President – AMER Michael J. Running reported equity transactions involving company common stock. On January 30, 2026, 1,820 Restricted Stock Units vested and settled into an equal number of Plexus common shares under the 2016 Omnibus Incentive Plan. On the same day, 894 shares were withheld at $199.33 per share to cover taxes, leaving him with 2,221 shares directly owned. On February 2, 2026, he sold 926 shares at an average price of $204.9201 per share, resulting in a remaining direct holding of 1,295 Plexus shares.
Plexus Corp executive Angelo Michael Ninivaggi Jr., Exec VP, CAO, General Counsel and Secretary, reported equity award activity. On January 30, 2026, 5,460 Restricted Stock Units granted under the Plexus Corp. 2016 Omnibus Incentive Plan vested and were converted into 5,460 shares of common stock at no cost.
On the same date, 2,602 shares of common stock were withheld at a price of $199.33 per share, reported with transaction code “F,” typically indicating shares withheld to cover taxes. After these transactions, Ninivaggi directly held 24,402 shares of Plexus Corp common stock.
Plexus Corp. executive Oliver K. Mihm, Exec VP & COO, reported equity award activity and a share disposition. On January 30, 2026, 7,280 Restricted Stock Units granted under the Plexus Corp. 2016 Omnibus Incentive Plan vested and settled into an equal number of common shares.
On the same date, 3,455 shares of Plexus common stock were disposed of at $199.33 per share, leaving Mihm with 22,267 shares held directly. In addition, 981 shares of Plexus common stock were held indirectly through the Plexus Corp. 401(k) Retirement Plan as of the plan trustee’s last report.
Plexus Corp President & CEO Todd P. Kelsey reported equity award vesting and subsequent share sales. On January 30, 2026, 31,290 restricted stock units converted into the same number of common shares, with 14,724 shares withheld at $199.33 per share, typically to cover taxes.
On February 3, 2026, Kelsey sold several blocks of Plexus common stock, including 3,837 shares at a weighted average price of $204.5332 and 2,163 shares at $205.8826, plus smaller trades at higher prices. After these transactions, he directly owned 78,598 Plexus shares.